Enhance your practice with CME and tools that focus on diseases and conditions impacting the female patient.
Rapid Data Pulses From ASCO 2026: Emerging Data on Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
Shared Goals, Shared Gains: Align With Patient Preferences
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
When to Begin FcRn: Initiation Criteria, Key Evidence
Minimal By Design: Define MSE Endpoints
Target Locked in gMG: Why T2T Matters
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
FcRn: Same Class, Different Paths—Spot Agent Differentiators
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
22nd Annual Women’s Health Annual Visit (WHAV)
Multiple dates & locations available
Turning Flares Into Function: Flag Uncontrolled Disease
Not Just a Headache: Migraine Across Women’s Lifespan
Jelena Pavlović, MD, PhD
Amaal J. Starling, MD, FAHS, FAAN
Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden
Gideon Hirschfield, MB, BChir, PhD
Marlyn Mayo, MD
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Karin J. Blakemore, MD
Emilie L. Vander Haar
Escalate With Intention: Stepwise, Target-Anchored Moves
The 2-Point Signal: Apply ≥2-Point Rule
The IgG Clock: Redose Using IgG Kinetics
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
Alison Kole, MD, MPH, FACCP
Ghada Bourjeily, MD, FCCP
Rashmi Nisha Aurora, MD
Audrey Wells, MD
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Lee P. Shulman, MD, FACMG, FACOG
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
Linda Bradley, MD
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
James A. Simon, MD, CCD, NCMP, IF, FACOG
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Sawsan As-Sanie, MD
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Kenneth J. Moise Jr., MD
Kara B. Markham, MD
Diagnosing and Treating IBS: It Begins With One Simple Question
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Kimberly D. Orleck, PA-C
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Samantha Denäe
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Melissa Simon, MD
Casey Joe Hinds
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Roberto Romero, MD, DMedSci
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.